(NYSE: INSP) Inspire Medical Systems's forecast annual revenue growth rate of 21.76% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Inspire Medical Systems's revenue in 2024 is $624,799,000.On average, 9 Wall Street analysts forecast INSP's revenue for 2024 to be $23,161,083,273, with the lowest INSP revenue forecast at $22,955,082,194, and the highest INSP revenue forecast at $23,552,701,294. On average, 9 Wall Street analysts forecast INSP's revenue for 2025 to be $28,131,291,989, with the lowest INSP revenue forecast at $26,614,759,558, and the highest INSP revenue forecast at $29,491,910,922.
In 2026, INSP is forecast to generate $33,444,184,966 in revenue, with the lowest revenue forecast at $31,561,388,947 and the highest revenue forecast at $34,856,281,980.